CHD7 and CHARGE syndrome: While molecular diagnosis was initially performed via traditional Sanger sequencing of CHD7, the recent application of whole exome sequencing in individuals suspected of having CHARGE syndrome has provided an opportunity to expand the number of pathogenic variants that have been detected in CHD7, as well as identifying additional genes associated with this disorder.